Diazoxide and D600 inhibition of insulin release. Distinct mechanisms explain the specificity for different stimuli.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001120:Arginine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D003864:Depression, Chemical; D003981:Diazoxide / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology; D005711:Gallopamil / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005947:Glucose / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D008239:Lysine / Q000494:pharmacology; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013806:Theophylline / Q000494:pharmacology; D014700:Verapamil / Q000031:analogs & derivatives*
D000317:Adrenergic alpha-Antagonists; D007328:Insulin; D005711:Gallopamil; D001120:Arginine; D013806:Theophylline; D014700:Verapamil; D005947:Glucose; D008239:Lysine; D003981:Diazoxide; D002118:Calcium; D004837:Epinephrine